Abstract
3/2022
vol. 39
Review paper
Lymphogranuloma venereum: an emerging problem in Poland
- Department of Dermatology and Venereology, Medical University of Warsaw, Warsaw, Poland
- Department of Gynaecological Endocrinology, Medical University of Warsaw, Warsaw, Poland
- WHO Collaborating Centre for Gonorrhoea and Other STIs, National Reference Laboratory for STIs, Faculty of Medicine and Health, Örebro University and Örebro University Hospital, Örebro, Sweden
- Department of General and Transplant Surgery, Medical University of Warsaw, Warsaw, Poland
Adv Dermatol Allergol 2022; XXXIX (3): 454-459
Online publish date: 2020/12/09
Lymphogranuloma venereum (LGV) is a sexually transmitted disease that increases in incidence, particularly in more developed countries worldwide. LGV is caused by Chlamydia trachomatis serovars/genovars L1-3, including their subvariants, and in Europe mostly affects men who have sex with men (MSM). It can be asymptomatic but has now emerged as a frequent cause of severe proctitis/proctocolitis, especially in MSM. LGV has often been misdiagnosed as C. trachomatis serovars/genovars D-K infection. It is essential with accurate diagnosis that ensures appropriate treatment and protects the patient from complications and sequelae as well as from the consequences of misdiagnosis, e.g. as inflammatory bowel disease or cancer. We present a systematic review of LGV and two new LGV cases diagnosed in Poland.
Keywords
lymphogranuloma venereum, men who have sex with men, Chlamydia trachomatis, sexually transmitted disease
Integrated with